EMSYN MET 12.5MG 500MG TAB

Emsyn Met 12.5mg/500mg Tablet, optimized for pharmacy websites and online product listings:

Emsyn Met 12.5mg/500mg Tablet – Dual Therapy for Type 2 Diabetes

Emsyn Met Tablet combines Vildagliptin (12.5mg) and Metformin (500mg), offering an effective oral antidiabetic solution for patients with type 2 diabetes mellitus. This dual-action formulation helps manage blood glucose levels when diet, exercise, or monotherapy is insufficient.

✅ Key Features & Benefits

• Vildagliptin (DPP-4 inhibitor) enhances insulin secretion and reduces glucagon production.

• Metformin (biguanide) improves insulin sensitivity and reduces hepatic glucose production.

• Helps lower HbA1c, fasting, and post-meal blood sugar levels.

• Low risk of hypoglycemia compared to other antidiabetics.

• Supports weight neutrality or modest weight loss.

📋 Indications

• For the treatment of adults with type 2 diabetes not adequately controlled by metformin alone or other oral agents.

• Can be used in combination with other antidiabetic medications under medical supervision.

💊 Dosage

• Typically one tablet twice daily, with meals to reduce gastrointestinal side effects.

• Dosage may vary based on glycemic control and patient condition.

⚠️ Precautions & Side Effects

• Not recommended for type 1 diabetes or diabetic ketoacidosis.

• Monitor kidney and liver function regularly.

• Common side effects: nausea, diarrhea, headache, mild GI upset.

📦 Packaging

• Available in blister packs, often containing 14 or 28 tablets.

• For prescription use only.